Intraocular Lenses

Match multifocal IOL to patient needs, preferences for best results
New EDOF IOL features novel optical design, reduced side effects, advanced chromatic optics
How to manage patient’s IOL expectations pre-operativelyPatient selection is the key factor in obtaining the best visual outcomes after cataract surgery and intraocular lens implantation.
Extended depth-of-focus IOLs may provide improved visual performanceAs your patients celebrate another birthday milestone, they are again back in your chair wondering why their reading glasses mysteriously disappear when they are out exploring life or why their arms are not as long as they used to be.
Innovations in cataract and refractive surgeryModern ophthalmic cataract surgery now employs sophisticated techniques to improve outcomes and patient satisfaction. This includes surgical systems providing better control, lasers to perform manual techniques, and intraoperative evaluation to evaluate surgical endpoints before the patient leaves the operating room (OR).
Effects of astigmatism greater on multifocals than monofocals IOLsThe effect of astigmatism varies with different factors and can affect patient satisfaction with multifocal or monofocal IOLs.
Comparing laser-assisted vs. conventional refractive cataract surgery
Comparing laser-assisted vs. conventional refractive cataract surgeryCataract surgery is one of the most commonly performed medical procedures and the leading diagnosis for outpatient surgery visits (3 million) in the U.S. In the past decade, the introductions of presbyopic and toric intraocular lenses (IOLs) have elevated cataract surgery into a refractive procedure. The latest introduction of femtosecond laser-assisted cataract surgery may further improve the predictability and safety of refractive cataract surgery and enhance refractive outcomes.
Valeant, Croma agreement to expand B + L surgical lineThe recent agreement between Valeant and Croma—which would provide for the distribution of Croma’s ophthalmology products in Western Europe—is expected to expand Bausch + Lomb’s (B + L) ophthalmic portfolio in the United States.
Valeant, Croma agreement to expand B + L surgical lineThe recent agreement between Valeant and Croma—which would provide for the distribution of Croma’s ophthalmology products in Western Europe—is expected to expand Bausch + Lomb’s (B + L) ophthalmic portfolio in the United States.
Editor’s Blog: IOLs again grab the attention at ESCRSThe European Society of Cataract and Refractive Surgeons (ESCRS) never fails to entice ophthalmology with cutting-edge technology, and the XXXII Congress in London has not disappointed attendees. This year’s congress has displayed a wide range of new technologies from cataract and refractive platforms to diagnostic units to surgical instruments. From all the equipment presented, IOL advances have again captured the attention of attendees.